Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Chinese drug maker Akeso hailed as biotech's 'DeepSeek moment' amid US competition
Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...
Merck & Co., Inc. (MRK): Among Top Dividend Contenders List
Top 15. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other top dividend ...
China’s biotech is redrawing the global pharma map; what India can learn
American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...
Notable healthcare headlines for the week: Merck, Novo Nordisk, J&J and Roche in focus
Wall Street's major averages closed in the green on Friday, but the benchmark S&P 500 (SP500) posted a four-week losing streak for the first time since early August last year as President Donald Trump ...
Philstar.com3h
Can Pogacar replace Merckx as the GOAT?
Eddy Merckx has won a total of 525 professional victories from 1965 to 1977. He has a winning percentage of 25% and retired at a relatively young age of 32. Pogacar is now 26 years old, has been ...